Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hidetake Matsuyoshi

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
BMC Ear, Nose, and Throat Disorders|April 27, 2013
Vestibular function in superficial siderosisToru Miwa, Ryosei Minoda, Hidetake Matsuyoshi
Plos One|August 5, 2021
Post-earthquake dizziness syndrome following the 2016 Kumamoto earthquakes, JapanToru Miwa, Hidetake Matsuyoshi, Yasuyuki Nomura, et al.
Nihon Rinsho. Japanese Journal of Clinical Medicine|May 3, 2005
[HLA mismatch and graft rejection]Hidetake Matsuyoshi, Satoru Senju, Mikio Monji, et al.
Auris, Nasus, Larynx|June 25, 2018
The effect of cochlear implants on vestibular-evoked myogenic potential responses and postural stabilityToru Miwa, Ryosei Minoda, Hidetake Matsuyoshi, et al.
Auris, Nasus, Larynx|April 18, 2025
Post-earthquake dizziness syndrome (PEDS): A comprehensive review of recent advancesToru Miwa, Keishi Fujiwara, Hidetake Matsuyoshi, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 7, 2004
Enhanced priming of antigen-specific CTLs in vivo by embryonic stem cell-derived dendritic cells expressing chemokine along with antigenic protein: application to antitumor vaccinationHidetake Matsuyoshi, Satoru Senju, Shinya Hirata, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 9, 2005
Prevention of experimental autoimmune encephalomyelitis by transfer of embryonic stem cell-derived dendritic cells expressing myelin oligodendrocyte glycoprotein peptide along with TRAIL or programmed death-1 ligandShinya Hirata, Satoru Senju, Hidetake Matsuyoshi, et al.
Frontiers in Bioscience (Elite Edition)|June 3, 2010
Pluripotent stem cell-derived dendritic cells for immunotherapySatoru Senju, Yusuke Matsunaga, Satoshi Fukushima, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 5, 2007
Involvement of regulatory T cells in the experimental autoimmune encephalomyelitis-preventive effect of dendritic cells expressing myelin oligodendrocyte glycoprotein plus TRAILShinya Hirata, Hidetake Matsuyoshi, Daiki Fukuma, et al.
Seminars in Immunopathology|April 5, 2011
Immunotherapy with pluripotent stem cell-derived dendritic cellsSatoru Senju, Yusuke Matsunaga, Satoshi Fukushima, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
BMC Ear, Nose, and Throat Disorders|April 27, 2013
Vestibular function in superficial siderosisToru Miwa, Ryosei Minoda, Hidetake Matsuyoshi
Plos One|August 5, 2021
Post-earthquake dizziness syndrome following the 2016 Kumamoto earthquakes, JapanToru Miwa, Hidetake Matsuyoshi, Yasuyuki Nomura, et al.
Nihon Rinsho. Japanese Journal of Clinical Medicine|May 3, 2005
[HLA mismatch and graft rejection]Hidetake Matsuyoshi, Satoru Senju, Mikio Monji, et al.
Auris, Nasus, Larynx|June 25, 2018
The effect of cochlear implants on vestibular-evoked myogenic potential responses and postural stabilityToru Miwa, Ryosei Minoda, Hidetake Matsuyoshi, et al.
Auris, Nasus, Larynx|April 18, 2025
Post-earthquake dizziness syndrome (PEDS): A comprehensive review of recent advancesToru Miwa, Keishi Fujiwara, Hidetake Matsuyoshi, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 7, 2004
Enhanced priming of antigen-specific CTLs in vivo by embryonic stem cell-derived dendritic cells expressing chemokine along with antigenic protein: application to antitumor vaccinationHidetake Matsuyoshi, Satoru Senju, Shinya Hirata, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 9, 2005
Prevention of experimental autoimmune encephalomyelitis by transfer of embryonic stem cell-derived dendritic cells expressing myelin oligodendrocyte glycoprotein peptide along with TRAIL or programmed death-1 ligandShinya Hirata, Satoru Senju, Hidetake Matsuyoshi, et al.
Frontiers in Bioscience (Elite Edition)|June 3, 2010
Pluripotent stem cell-derived dendritic cells for immunotherapySatoru Senju, Yusuke Matsunaga, Satoshi Fukushima, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 5, 2007
Involvement of regulatory T cells in the experimental autoimmune encephalomyelitis-preventive effect of dendritic cells expressing myelin oligodendrocyte glycoprotein plus TRAILShinya Hirata, Hidetake Matsuyoshi, Daiki Fukuma, et al.
Seminars in Immunopathology|April 5, 2011
Immunotherapy with pluripotent stem cell-derived dendritic cellsSatoru Senju, Yusuke Matsunaga, Satoshi Fukushima, et al.
Pageof 2